Paresh Patel

Paresh Patel is a former Head of Global Clinical Intelligence at Otsuka. He works on quality assurance and trust frameworks for AI in regulated industries. Paresh has spent many years in pharma and biotech across the US, Europe, and Japan, on the sponsor side, at CROs, and at sites. He is currently focused on bridging the gap between AI deployment and regulatory inspection-readiness in clinical and life-sciences settings.

Keegan Moore

Focused on helping to bring therapies to patients all over the world.

Results driven sales executive with successful sales leadership focused on developing and growing business relationships. Business management leader and entrepreneur with a track record of achievement in the pharmaceutical, aerospace, finance, and transportation industries.

Yuyi Shen

Experienced and self-motivated process development scientist and team leader with specialty in process improvement, scale up, technical transfer to bioprocess manufacturing in cGMP environment. Strong subject matter experts in design robust processes for protein purification with monoclonal antibody, antigen and VLP etc, ensuring Critical Quality Attributes are achieved.

Solid trouble shooting and problem solving skills and encouraging innovation technology to achieve high efficiency and avoid repetitive work.

Strong proven track of define, design, manage and deliver projects upon all milestones, goals and cost target.

Build, develop, train and supervise team members and engage and motivate members to ensure the overall success and growth.

Frank Trampert

Frank Trampert is Sabre Hospitality Solutions’ SVP and Global Managing Director Commercial. Frank is responsible for business and financial performance, customer engagement and overall growth and development at a global level.

Frank has valuable experience in both hospitality processes and technology, having held highly sought-after leadership positions with the Wyndham Hotel Group in Hong Kong, Carlson Hotels across four continents, Brand Karma in Singapore, and most recently, as the CEO for Tune Hotel Group in Malaysia.

Frank started his career in hospitality in Europe and has since lived and worked across four continents. He has assisted in expanding some of the largest global hospitality companies internationally and his diverse background in international franchise and hotel management ranges from limited service to luxury hotels.

He is an experienced and successful hotelier, having managed a diverse workforce while leading high performance teams. Frank enjoys the complexities of international businesses, enabling him to not only run his own advisory firm but also to join a technology start-up focused on cloud based social media solutions for the global hospitality sector.

Frank is married with two children. Frank holds a bachelor’s degree in hospitality management from the College of Hotel Management in Heidelberg, Germany and speaks English, German and French.

Jef Benbanaste

Jef Benbanaste has led the launch and commercialization of multiple analytical SaaS solutions at Medidata and currently leads Intelligent Trials. Jef has over 16 years of experience improving business processes and decision-making through the use of technology and analytics.

Prior to joining Medidata, Jef led projects at the global insurance company AIG which applied predictive modeling and machine learning techniques to improve risk segmentation and shape business unit strategies. Before that, he was in technology consulting at Deloitte. Jef has a MBA from MIT and a BS from the University of Virginia.

Kelly Snow

As head of strategic initiatives and a member of the executive leadership team at Suvoda, Kelly is responsible for driving strategic growth across the organization. Prior to this, Kelly spent 4 years as VP of Product Management and Marketing at Suvoda, where she led the strategic direction of the product suite and external communications. She has spent her career in professional services and product development teams, working with Top 10 Pharma companies in e-clinical focused organizations including Phase Forward and Oracle, as well as B2C technology companies. Kelly holds a bachelor’s degree in Interdisciplinary Studies in Bioethics focusing on Neuroscience and Philosophy, a certificate in Conceptual Foundations of Medicine, and a minor in Italian Literature and Language from the University of Pittsburgh.

Michael O’Neal

Michael O’Neal, MD, is Chief Medical Officer at Bioclinica. As a key member of the senior executive team, Dr. O’Neal is responsible for overseeing all medical affairs efforts within the organization, providing strategic leadership to clinical teams while collaborating with sponsors in all aspects of medical imaging protocol development. Drawing on extensive clinical experience in internal medicine and diagnostic radiology, he oversees physician training, service quality, and process improvements while advising on medical operations, regulatory compliance, and the investment of new technologies across medical imaging.

During his 17 years with Bioclinica, Dr. O’Neal has developed and championed improved standards that enable research sites to produce comparable study data across the globe and has provided oversight of imaging data for more than 75 regulatory approvals. Throughout his tenure, he has played a central role in protocol review, charter development, a reader on multiple trials, and independent oversight of over 400 clinical trials to date. He is a member of professional organizations including the Radiological Society of North America, the American College of Radiology, the American Medical Association, the Drug Information Association, the American Society for Clinical Oncology, and the American Society of Hematology. In 2019, he was recognized by PharmaVOICE magazine as one of the “100 Most Inspiring People in the Life-Sciences Industry”.

Prior to his role at Bioclinica, Dr. O’Neal served as Chairman for the Department of Radiology at the Hospital Center at Orange and the head of Central Medical Imaging MRI center. Dr. O’Neal holds certification in Diagnostic Radiology from the American College of Radiology, in addition to fellowship training in Body Imaging. He is the author of several papers, a speaker at many industry meetings, and was a contributor to the iRECIST Committee prior to publication.